GoodRx, a platform for medication savings, highlights seven commonly overlooked deductions and how to claim them.

TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...

Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy red patches on his skin. Then came the pain and swelling in the joints of his hands, making it ...

GoodRx (NASDAQ:GDRX) executives said the company ended 2025 with what it called “disciplined execution” across strategic priorities, while preparing investors for near-term pressure on revenue and pro ...

GoodRx Holdings, Inc. ( GDRX) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2025 Earnings ...

The Trump administration's new website, TrumpRx, is a poor imitation of GoodRx with fewer options, and does not provide real relief for families struggling with high drug prices.

In the case of brand-name Crestor (rosuvastatin), the average retail price is close to $400 for one month, while a three-month supply at a national pharmacy is $780. For generic rosuvastatin (which ...

The Trump administration’s new website, TrumpRx, is a poor imitation of GoodRx with fewer options, and does not provide real ...

Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous GuidancePharma Direct Revenue Beats Previous Outlook with Over 40% Year-Over-Year Growth for 2025SANTA ...

David Graziano, head of retail network at GoodRx, says the FDA’s crackdown on non-approved or “copycat” GLP-1 drugs could shift demand toward FDA-approved therapies while increasing the importance of ...

Drug pricing 2026 forces are reshaping pharmacy economics through Medicare negotiations, FTC actions, and federal pricing models.

David Graziano, head of retail network at GoodRx, says the FDA’s crackdown on non-approved or “copycat” GLP-1 drugs could shift demand toward FDA-approved therapies while increasing the importance of ...